Incyte: Buy For The Turnaround, Stay For The Pipeline [Seeking Alpha]
Incyte Corporation (INCY)
Last incyte corporation earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
incyte.com/ir/investor-overview.aspx
Company Research
Source: Seeking Alpha
Jakafi sales rose 6.7% YoY in Q3 2025, defying terminal decline fears, while ex-Jakafi business surged 45% YoY. Management projects ex-Jakafi revenues to triple by 2030, with pipeline catalysts and Jakafi XR mitigating the 2028 patent cliff. INCY stock trades at just 13.7x 2026 EPS, with market expectations still overly bearish, despite a $10B+ pipeline opportunity. Bo Shen/iStock Editorial via Getty Images Last February , I rated Incyte Corporation ( INCY ) a Strong Buy anticipating a turnaround for the stock. At the time, the market was fixated on the putative decline of the company's top-selling drug Jakafi This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of INCY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock
Show less
Read more
Impact Snapshot
Event Time:
INCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INCY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INCY alerts
High impacting Incyte Corporation news events
Weekly update
A roundup of the hottest topics
INCY
News
- Incyte's Pipeline Potential Signals Massive Upside For Investors [Seeking Alpha]Seeking Alpha
- Factbox-Pharma sector doubles down on AI amid hopes of slashing costs, timelines [Yahoo! Finance]Yahoo! Finance
- Earnings Preview: What To Expect From Incyte's Report [Yahoo! Finance]Yahoo! Finance
- Why Incyte (INCY) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Incyte CEO Bill Meury: Blood cancer therapy development is company's central identity [CNBC]CNBC
INCY
Earnings
- 10/28/25 - Beat
INCY
Sec Filings
- 1/8/26 - Form 4
- 1/7/26 - Form 4
- 1/7/26 - Form 144
- INCY's page on the SEC website